Articles by Philip Ridley-Smith - BioPharm International

ADVERTISEMENT

ADVERTISEMENT
Articles by Philip Ridley-Smith

Biosimilars Regulation in the US: The Challenges

The pathway for biosimilar approval in the US has been set. But are US patients too far behind Europe?
Nov 1, 2010
By: Philip Ridley-Smith

The pathway for biosimilar approval in the US has been set. But are US patients too far behind Europe?

ADVERTISEMENT

ADVERTISEMENT
Click here